These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11357487)

  • 21. Effect of insulin and sulfonylurea therapy, at the same level of blood glucose control, on low density lipoprotein subfractions in type 2 diabetic patients.
    Rivellese AA; Patti L; Romano G; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4188-92. PubMed ID: 11095452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapeutic management of the secondary failure of sulfonylurea therapy].
    Sauer H
    Dtsch Med Wochenschr; 1985 Jan; 110(1):27-30. PubMed ID: 3880697
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of gliclazide on non-insulin dependent diabetes mellitus.
    Wajchenberg BJ; Santomaruo AT; Cherem JJ; Malerbi DA; Giurno Filho A; Lerario AC; Giannella Neto D
    Adv Exp Med Biol; 1988; 246():313-9. PubMed ID: 3074661
    [No Abstract]   [Full Text] [Related]  

  • 24. Unsubstantiated concerns over the safety of use of sulphonylureas and insulin for increased risk of diabetes complications.
    Weng J; Yang X
    J Diabetes; 2014 Jan; 6(1):30-2. PubMed ID: 23944992
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical efficacy of glimepiride].
    Kaneko T; Sakamoto N
    Nihon Rinsho; 1997 Nov; 55 Suppl():152-7. PubMed ID: 9434460
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
    Nauck MA; Sauerwald A; Ritzel R; Holst JJ; Schmiegel W
    Diabetes Care; 1998 Nov; 21(11):1925-31. PubMed ID: 9802745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Follow-up of intensive glucose control in type 2 diabetes.
    Lund SS; Rossing P; Vaag AA
    N Engl J Med; 2009 Jan; 360(4):416; author reply 418. PubMed ID: 19164195
    [No Abstract]   [Full Text] [Related]  

  • 28. Second line therapy: type 2 diabetic subjects failing on metformin GLP-1/DPP-IV inhibitors versus sulphonylurea/insulin: for GLP-1/DPP-IV inhibitors.
    Kumar A
    Diabetes Metab Res Rev; 2012 Dec; 28 Suppl 2():21-5. PubMed ID: 23280862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preliminary results of non-insulin dependent diabetes mellitus treated with glipizide].
    Lu JM; Pan CY; Li CF
    Zhonghua Nei Ke Za Zhi; 1988 Mar; 27(3):143-6, 196. PubMed ID: 3219929
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
    Khandekar S; Sethi BK; Dash RJ
    J Assoc Physicians India; 1990 Jul; 38(7):469-71. PubMed ID: 2127273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does cellular glucose transport respond to a controlled diet and sulfonylurea therapy in type 2 diabetes mellitus?
    Tatoń J; Piatkiewicz P; Czech A
    Endokrynol Pol; 2010; 61(1):75-81. PubMed ID: 20205108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glimepiride and serum adiponectin level in type 2 diabetic subjects: response to Nagasaka et al.
    Yoshioka K; Yoshida T; Yoshikawa T
    Diabetes Care; 2003 Dec; 26(12):3360-1; author reply 3361. PubMed ID: 14633838
    [No Abstract]   [Full Text] [Related]  

  • 33. [Testing insulin and sulfonylurea sensitivity in type II diabetes mellitus].
    Holländer E
    Orv Hetil; 1984 Dec; 125(51):3103-6. PubMed ID: 6392996
    [No Abstract]   [Full Text] [Related]  

  • 34. Some answers, more controversy, from UKPDS. United Kingdom Prospective Diabetes Study.
    Nathan DM
    Lancet; 1998 Sep; 352(9131):832-3. PubMed ID: 9742972
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of type 2 diabetes mellitus with special reference to metformin therapy.
    Campbell IW
    Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide.
    Massi-Benedetti M; Herz M; Pfeiffer C
    Horm Metab Res; 1996 Sep; 28(9):451-5. PubMed ID: 8911982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of sulphonylureas in the management of type 2 diabetes mellitus.
    Rendell M
    Drugs; 2004; 64(12):1339-58. PubMed ID: 15200348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controversies in management of diabetes in patients with coronary heart disease.
    Abdella NA
    Med Princ Pract; 2002; 11 Suppl 2():69-74. PubMed ID: 12444313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapy of diabetes mellitus in "secondary failure of sulfonylurea compounds"].
    Bachmann W
    Med Klin (Munich); 1987 Jun; 82(14):491-4. PubMed ID: 3302644
    [No Abstract]   [Full Text] [Related]  

  • 40. Workshop VIII--Retinopathy, nephropathy, neuropathy, and tight control.
    Lebovitz HE; Vinik AI
    Am J Med; 1991 Feb; 90(2A):80S-84S. PubMed ID: 1994725
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.